Compile Data Set for Download or QSAR
Report error Found 67 Enz. Inhib. hit(s) with all data for entry = 50022573
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 1nMAssay Description:Inhibition of human AMPK alpha1/beta1/gamma1 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of PAK4 Kinase domain (291 to 591 residues) (unknown origin) transfected in TR-293-KDG cells using GEFH1 as substrate assessed as inhibiti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 2nMAssay Description:Inhibition of human RSK1 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 2nMAssay Description:Inhibition of human RSK2 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKd:  2.70nMAssay Description:Binding affinity to PAK4 catalytic domain (unknown origin) assessed as equilibrium dissociation constant at 50 uM by ITC analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  3nMAssay Description:Inhibition of human CHK2 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKd:  4.5nMAssay Description:Binding affinity to biotin-tagged PAK4 (unknown origin) assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  5nMAssay Description:Inhibition of human RSK1 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  5nMAssay Description:Inhibition of human RSK2 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  5nMAssay Description:Inhibition of human AMPK alpha1/beta1/gamma1 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  10nMAssay Description:Inhibition of human PKCtheta assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  11nMAssay Description:Inhibition of human RSK3 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 13nMAssay Description:Inhibition of human CHK2 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  14nMAssay Description:Inhibition of PAK1 (unknown origin) using Syntide-2 PLARTLSVAGLPGKK peptide as substrate assessed as inhibition constant in presence of ATP by bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  15nMAssay Description:Inhibition of human PRKG1 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  15nMAssay Description:Inhibition of human FGR assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 17nMAssay Description:Inhibition of PAK6 (unknown origin) using EVPRRKSLVGTPYWM peptide as substrate assessed as inhibition constant in presence of ATP by biochemical assa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  18nMAssay Description:Inhibition of PAK5 (unknown origin) using EVPRRKSLVGTPYWM peptide as substrate assessed as inhibition constant in presence of ATP by biochemical assa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  19nMAssay Description:Inhibition of N-terminal 6His-tagged human recombinant PAK4 kinase domain (300 to 591 residues) using EVPRRKSLVGTPYWM peptide as substrate assessed a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  21nMAssay Description:Inhibition of human PKD2 (PRKD2) assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  21nMAssay Description:Inhibition of human PKCmu assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 21nMAssay Description:Inhibition of human PKCmu in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 23nMAssay Description:Inhibition of human FGR in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  26nMAssay Description:Inhibition of human FYN assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 26nMAssay Description:Inhibition of human PKD2 (PRKD2) in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 28nMAssay Description:Inhibition of human PKCtheta in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  32nMAssay Description:Inhibition of human SRC assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 34nMAssay Description:Inhibition of human PRKG1 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 40nMAssay Description:Inhibition of human AMPK alpha1/beta1/gamma1 in presence of ATP by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  43nMAssay Description:Inhibition of human YES1 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  43nMAssay Description:Inhibition of human PKCgamma assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 46nMAssay Description:Inhibition of human FYN in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 47nMAssay Description:Inhibition of human YES1 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 55nMAssay Description:Inhibition of human SRC in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 59nMAssay Description:Inhibition of human PKCgamma in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  81nMAssay Description:Inhibition of human FLT3 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  81nMAssay Description:Inhibition of human PRK1 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 82nMAssay Description:Inhibition of human PRK1 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 96nMAssay Description:Inhibition of human FLT3 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 99nMAssay Description:Inhibition of PAK3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 156nMAssay Description:Inhibition of human PKCbeta-II in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 171nMAssay Description:Inhibition of human RSK2 in presence of ATP by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  172nMAssay Description:Inhibition of human AKT3 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKi:  185nMAssay Description:Inhibition of human PKCbeta1 assessed as inhibition constant in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 190nMAssay Description:Inhibition of PAK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 280nMAssay Description:Inhibition of human PKCbeta1 in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 302nMAssay Description:Inhibition of human CHK2 in presence of ATP by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 407nMAssay Description:Inhibition of human FLT3 in presence of ATP by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 513nMAssay Description:Inhibition of human TRKa in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 543nMAssay Description:Inhibition of human RSK1 in presence of ATP by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: